Aspergillus tubingensis pneumonia with pulmonary oxalosis in a virologically suppressed person with HIV: A case report.

J Infect ChemotherSep 30, 2026 (epub)

Ryoko Sekiya, Tatsuya Inukai, Mihoko Yotsumoto et al.

✦ AI-curated · Sources linked

Case in brief

A man in his late sixties with virologically suppressed HIV and a CD4 count of 368/μL developed cough, then fever and dyspnea requiring hospitalization. CT showed bilateral pneumonia and a right upper-lobe cavity. PCR-based analysis with DNA sequencing identified Aspergillus tubingensis; susceptibility testing showed reduced susceptibility to multiple azoles. Voriconazole alone failed, while voriconazole plus micafungin brought partial clinical improvement. Pulmonary oxalosis developed. After partial radiological improvement, he was discharged on long-term voriconazole but required home oxygen for chronic respiratory insufficiency. He died after 2.5 years; autopsy showed extensive pulmonary fibrosis, traction bronchiectasis, and hyaline membrane formation.

What made this case unusual

Infection occurred despite virologic suppression and a preserved CD4 count. The isolate had reduced susceptibility to multiple azoles, and the course was complicated by pulmonary oxalosis and substantial chronic lung damage.

Diagnostic / clinical pearl

Consider invasive aspergillosis in a person with HIV even when viral suppression and CD4 status appear reassuring; species identification and susceptibility testing can be important when azole therapy fails.

Source

Published in J Infect Chemother. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.